Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-05 Sale | 2024-07-08 5:55 pm | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 2,638 | $2.5077 | $6,615 | 242,045 (Direct) | View |
| 2024-05-13 Sale | 2024-05-15 4:07 pm | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 8,151 | $4.7888 | $39,034 | 209,683 (Direct) | View |
| 2024-01-03 Sale | 2024-01-08 06:02 am | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 4,081 | $3.0877 | $12,601 | 207,234 (Direct) | View |
| 2022-01-05 Sale | 2022-01-05 8:24 pm | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 1,445 | $10.61 | $15,334 | 74,555 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-18 Disposition | 2024-09-18 4:15 pm | N/A 2034-01-03 | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 367,110 | $0 | 0 (Direct) | View |
| 2024-09-18 Equity Swap | 2024-09-18 4:15 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 26,035 | $0 | 0 (Direct) | View |
| 2024-09-18 Option Award | 2024-09-18 4:15 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 20,600 | $0 | 0 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 5:26 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 35,000 | $0 | 244,683 (Direct) | View |
| 2024-03-20 Option Award | 2024-03-22 4:09 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 100,000 | $0 | 217,834 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-08 06:02 am | N/A 2034-01-03 | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 134,160 | $0 | 207,234 (Direct) | View |
| 2023-05-10 Option Award | 2023-05-12 4:20 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 35,000 | $0 | 77,155 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 8:25 pm | N/A 2033-01-03 | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 61,700 | $0 | 83,255 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 8:24 pm | N/A 2032-01-03 | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 65,000 | $0 | 74,555 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-05 6:10 pm | N/A 2031-01-04 | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 69,000 | $0 | 69,000 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-07 4:15 pm | N/A 2030-02-06 | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 60,000 | $0 | 60,000 (Direct) | View |